Biotechnology company Bavarian Nordic (BAVA.CO) expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its...
Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and oversubscribed Series A financing...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the U.S. Food and Drug Administration...
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from...
Sanofi today launches Action 2022, its global employee share ownership plan, open to 86 000 employees in 59 countries. The program, similar to programs...